JPH0316923B2 - - Google Patents
Info
- Publication number
- JPH0316923B2 JPH0316923B2 JP57216871A JP21687182A JPH0316923B2 JP H0316923 B2 JPH0316923 B2 JP H0316923B2 JP 57216871 A JP57216871 A JP 57216871A JP 21687182 A JP21687182 A JP 21687182A JP H0316923 B2 JPH0316923 B2 JP H0316923B2
- Authority
- JP
- Japan
- Prior art keywords
- atractylodine
- tablets
- results
- choleretic
- once
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000731 choleretic agent Substances 0.000 claims description 5
- 239000004480 active ingredient Substances 0.000 claims description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 9
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 8
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 230000001989 choleretic effect Effects 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 239000003814 drug Substances 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000008187 granular material Substances 0.000 description 4
- 235000019359 magnesium stearate Nutrition 0.000 description 4
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 4
- FKJIJBSJQSMPTI-CAOXKPNISA-M sodium;(4r)-4-[(5s,8r,9s,10s,13r,14s,17r)-10,13-dimethyl-3,7,12-trioxo-1,2,4,5,6,8,9,11,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]pentanoate Chemical compound [Na+].C1CC(=O)C[C@H]2CC(=O)[C@H]3[C@@H]4CC[C@H]([C@@H](CCC([O-])=O)C)[C@@]4(C)C(=O)C[C@@H]3[C@]21C FKJIJBSJQSMPTI-CAOXKPNISA-M 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 241000700159 Rattus Species 0.000 description 3
- 210000000941 bile Anatomy 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 210000000013 bile duct Anatomy 0.000 description 2
- 238000004440 column chromatography Methods 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 231100000517 death Toxicity 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- -1 polyethylene Polymers 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- 241000208838 Asteraceae Species 0.000 description 1
- 241000132011 Atractylodes lancea Species 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 235000013555 soy sauce Nutrition 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Furan Compounds (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP57216871A JPS59106421A (ja) | 1982-12-13 | 1982-12-13 | 利胆剤 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP57216871A JPS59106421A (ja) | 1982-12-13 | 1982-12-13 | 利胆剤 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS59106421A JPS59106421A (ja) | 1984-06-20 |
JPH0316923B2 true JPH0316923B2 (enrdf_load_stackoverflow) | 1991-03-06 |
Family
ID=16695215
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP57216871A Granted JPS59106421A (ja) | 1982-12-13 | 1982-12-13 | 利胆剤 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS59106421A (enrdf_load_stackoverflow) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6409415B2 (ja) * | 2014-08-26 | 2018-10-24 | 株式会社ツムラ | アトラクチロジン類の製造方法、及び、コバルト錯体化合物 |
CN106727487A (zh) * | 2016-12-29 | 2017-05-31 | 泰州中国医药城中医药研究院 | 苍术素在制药中的应用 |
-
1982
- 1982-12-13 JP JP57216871A patent/JPS59106421A/ja active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS59106421A (ja) | 1984-06-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101035548B (zh) | 甾体皂苷药物组合物及其制备方法和应用 | |
JPH0256329B2 (enrdf_load_stackoverflow) | ||
RU2000120474A (ru) | Фармацевтическая композиция, обладающая противоопухолевой активностью и способ ее получения | |
JPH0316923B2 (enrdf_load_stackoverflow) | ||
CN102342945A (zh) | 救必应皂苷化合物用于制备抗炎镇痛药物 | |
JPH0144167B2 (enrdf_load_stackoverflow) | ||
JPH0358330B2 (enrdf_load_stackoverflow) | ||
JPH0256330B2 (enrdf_load_stackoverflow) | ||
JP2540871B2 (ja) | 抗高脂血症剤 | |
JPS58172320A (ja) | 抗高脂血症剤及びその製造方法 | |
CN111450143B (zh) | 小叶榕叶提取物在制备预防和/或治疗肝脏病变的药物中的用途 | |
JPH0354646B2 (enrdf_load_stackoverflow) | ||
JP3717189B2 (ja) | 鎮痛抗炎症剤 | |
JPH07267864A (ja) | 体温降下剤 | |
JPH0261921B2 (enrdf_load_stackoverflow) | ||
JPS58152819A (ja) | 利胆剤 | |
JPS5938206B2 (ja) | 補酵素qを主成分とする気管支喘息治療剤 | |
JPH0369327B2 (enrdf_load_stackoverflow) | ||
JP3183758B2 (ja) | 血中中性脂肪改善剤及びその製造方法並びにこれを含有する組成物 | |
JPH02255621A (ja) | 降圧剤 | |
JPH0672870A (ja) | 抗潰瘍剤 | |
JPH0469617B2 (enrdf_load_stackoverflow) | ||
JPH0469619B2 (enrdf_load_stackoverflow) | ||
JPH07258104A (ja) | 癌転移抑制剤 | |
JPS63239230A (ja) | 発癌予防剤 |